Panadol Children 5-12 Years

Panadol is one of the world's most recognized names in pain relief, with a history dating back to its commercial introduction in 1955 by Phillips, Scott & Turner. The brand was later developed by Sterling Drug and went through several corporate acquisitions involving Eastman Kodak, SmithKline Beecham, and eventually GlaxoSmithKline (GSK). In 2022, as part of a significant corporate restructuring, GSK spun off its consumer healthcare division to form Haleon, which now manages the Panadol brand globally.

For the Australian market, Children's Panadol is a staple of household medicine cabinets. Since 2018, much of the production for the Australian and regional markets has been centered in Victoria. Specifically, many Panadol products, including various liquid and tablet forms, are manufactured at the Aspen Australia facility in Dandenong, Victoria, following a landmark contract intended to boost local pharmaceutical manufacturing. This local production ensures that the product meets the stringent quality standards of the Australian Therapeutic Goods Administration (TGA), where it is registered under specific 'AUST R' numbers visible on the packaging.